Almstead Neil Gregory bought PTCT
November 25, 2025 · Form 4 insider transaction
Almstead Neil Gregory bought 11,399 shares of PTC Therapeutics, Inc. at $33.02 per share, a transaction worth $376.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,399
Price
$33.02
Total value
$376.4K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 25, 2025
Filing dateNovember 26, 2025
Shares owned after112,024
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024.